BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5759432)

  • 1. [Activation of protective reactions of the organism in malignant growths].
    Balitskiĭ KP; Struk VI
    Zh Eksp Klin Med; 1968; 8(2):3-8. PubMed ID: 5759432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective effect of prodigiosan in acute respiratory disease in children's collectives].
    Vinogradov VP
    Mikrobiol Zh; 1971; 33(6):789. PubMed ID: 5153575
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indices of outer respiration in complex therapy of chronic pneumonia using prodigiosin].
    Olgina FP; Ivanova TI; Neĭko EM; Kekalo LA
    Antibiotiki; 1972 Mar; 17(3):243-5. PubMed ID: 5030777
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prodigiozan and antibiotics].
    Ermol'eva ZV; Vaĭsberg GE
    Antibiotiki; 1972 Dec; 17(12):1109-28. PubMed ID: 4572479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prodigiosan in the complex treatment of eczema, neurodermatitis and prurigo in children].
    Danielian EE
    Vestn Dermatol Venerol; 1970 Dec; 44(12):50-2. PubMed ID: 5516667
    [No Abstract]   [Full Text] [Related]  

  • 6. [Assessment of the effect of prodigiosan in chronic recurrent aphthous stomatitis].
    Lialina MI; Savkina GD
    Stomatologiia (Mosk); 1971; 50(3):15-6. PubMed ID: 4933191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stimulants in the complex treatment of periodontosis].
    Mashenko IS
    Stomatologiia (Mosk); 1969; 48(3):37-8. PubMed ID: 5256281
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of zymosan on the toxicity and activity of various antitumor preparations].
    Veksler IG
    Vopr Onkol; 1966; 12(8):80-6. PubMed ID: 4972211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of prodigiosin aerosol inhalation on immunobiological reactivity in experiments].
    Ermol'eva ZV; Vaĭsberg GE; Taranenko AL; Eĭdel'shtein SI; Prokhorova II
    Antibiotiki; 1971 Dec; 16(12):1076-81. PubMed ID: 5140749
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of polysaccharide prodigiozan in the complex therapy of chronic and residual brucellosis].
    Kushnareva TO; Givental' NI; Andreeva PG
    Antibiotiki; 1971 Jun; 16(6):567-71. PubMed ID: 4939471
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of adaptogens on the growth and metastasis of Pliss lymphosarcoma during laparotomy].
    Moskalik KG
    Vopr Onkol; 1970; 16(7):74-8. PubMed ID: 5536602
    [No Abstract]   [Full Text] [Related]  

  • 12. [The mechanism of the stimulating effect of dibazol and a vitamin complex (B1, B2, B9, PP, C) on immunity to diphtheria].
    Manolova EP
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):31-4. PubMed ID: 4239544
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prospects for using antibiotics with sulfanilamides].
    Sakanian SSh
    Veterinariia; 1979 May; (5):62-4. PubMed ID: 452399
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a red-pigmented bacterium producing a potent anti-tumor N-alkylated prodigiosin as Serratia marcescens.
    Deorukhkar AA; Chander R; Ghosh SB; Sainis KB
    Res Microbiol; 2007 Jun; 158(5):399-404. PubMed ID: 17467243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of gram-negative bacterial polysaccharides on various immunity reactions and experimental tumors].
    Slabospyts'ka AT; Zatula DH; Zakharova IIa; Reznyk SR
    Mikrobiol Zh; 1976; 38(6):750-5. PubMed ID: 794646
    [No Abstract]   [Full Text] [Related]  

  • 16. [Several aspects of the anti-inflammatory activity of dibazol].
    Sokolova SA; Mednik GL
    Farmakol Toksikol; 1973; 26(4):468-70. PubMed ID: 4789899
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stimulation of natural immunity to infection evoked by Escherichia coli with benzimidazole derivatives].
    Braude AT; Bukharin OV
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Mar; 45(3):36-40. PubMed ID: 4892091
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic synergism.
    Mantal N
    Cancer Chemother Rep 2; 1974 Mar; 4(1):147-9. PubMed ID: 4826493
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental tumour immunology.
    Nagy I; Ats M; Koszoru M; Majorossy K
    Arch Ital Patol Clin Tumori; 1966; 9(1):81-7. PubMed ID: 5998090
    [No Abstract]   [Full Text] [Related]  

  • 20. Consecutive, multimodal therapy of cancer: selective biological initiation (OK-432), cytoplasmic and nuclear damage (FT-207 and cyclophosphamide), inhibition of repair (bleomycin), and activation of cleansing and surveillance mechanisms.
    Okuyama S; Mishina H
    Sci Rep Res Inst Tohoku Univ Med; 1981 Dec; 28(1-4):7-14. PubMed ID: 6179159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.